Hims & Hers Health (HIMS) Revenue (2020 - 2026)
Hims & Hers Health (HIMS) posted Revenue of $608.1 million for Q1 2026, down 1.57% sequentially from $617.8 million in Q4 2025, and up 3.77% YoY from $586.0 million in Q1 2025.
Hims & Hers Health (HIMS) Revenue (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Revenue for 7 years, with the latest figure at $608.1 million in Q1 2026.
- Quarterly Revenue rose 3.77% year-over-year to $608.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 32.81% YoY) and the FY2025 annual result came in at $2.3 billion, up 59.0% from the prior year.
- Revenue retreated to $608.1 million in Q1 2026 per HIMS's latest filing, from $617.8 million in the prior quarter.
- Over five years, Revenue peaked at $617.8 million in Q4 2025 and troughed at $101.3 million in Q1 2022.
- A 5-year average of $343.0 million and a median of $278.2 million in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2025 and 2026: Revenue surged 110.67% in 2025, then advanced 3.77% in 2026.
- Over 5 years, Revenue stood at $167.2 million in 2022, then jumped by 47.5% to $246.6 million in 2023, then jumped by 95.09% to $481.1 million in 2024, then gained by 28.41% to $617.8 million in 2025, then decreased by 1.57% to $608.1 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $608.1 million, $617.8 million, and $599.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.78 Bn | 42.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.24 Bn | 39.59 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.66 Bn | 29.98 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.80 Bn | 17.91 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.64 Bn | 15.25 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Hims & Hers Health | 7.63 Bn | 6.79 Bn | 480.80 Mn | 753.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 753.21 Mn |
| Mar 31, 2026 | 608.10 Mn |
| Dec 31, 2025 | 617.82 Mn |
| Sep 30, 2025 | 598.98 Mn |
| Jun 30, 2025 | 544.83 Mn |
| Mar 31, 2025 | 586.01 Mn |
| Dec 31, 2024 | 481.14 Mn |
| Sep 30, 2024 | 401.56 Mn |
| Jun 30, 2024 | 315.65 Mn |
| Mar 31, 2024 | 278.17 Mn |
| Dec 31, 2023 | 246.62 Mn |
| Sep 30, 2023 | 226.70 Mn |
| Jun 30, 2023 | 207.91 Mn |
| Mar 31, 2023 | 190.77 Mn |
| Dec 31, 2022 | 167.20 Mn |
| Sep 30, 2022 | 144.84 Mn |
| Jun 30, 2022 | 113.56 Mn |
| Mar 31, 2022 | 101.31 Mn |
| Dec 31, 2021 | 84.70 Mn |
| Sep 30, 2021 | 74.17 Mn |